George Eric Davis is CLO & VP at BIOMARIN PHARMACEUTICAL INC (BMRN). They have made 55 open-market trades across 1 company since 2007, most recently 2026-03-18.
CIK 0001380710
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $35K since 2007, against 53 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BMRN | 78,560 | $4.5M |
Shares reported on the most recent Form 4, priced at the 2026-03-19 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BMRN | SELL | 2026-02-26 | 2026-02-26 | $61.36 | $1.6M | +0.0% | -10.0% | -14.0% |
| BMRN | SELL · 10b5-1 | 2024-05-28 | 2024-05-30 | $74.52 | $6.1M | +12.5% | +10.2% | +21.2% |
| BMRN | SELL · 10b5-1 | 2024-05-02 | 2024-05-06 | $85.01 | $315K | -6.6% | -3.3% | -2.3% |
| BMRN | SELL · 10b5-1 | 2024-03-28 | 2024-04-01 | $88.34 | $4.3M | +6.0% | -3.4% | -4.8% |
| BMRN | SELL · 10b5-1 | 2023-12-13 | 2023-12-14 | $95.30 | $2.6M | +0.2% | -4.3% | -13.2% |
| BMRN | SELL | 2023-08-08 | 2023-08-09 | $89.42 | $984K | -3.6% | -3.2% | -8.3% |
| BMRN | SELL | 2022-08-09 | 2022-08-11 | $95.96 | $9.8M | -3.3% | -4.8% | -14.6% |
| BMRN | SELL | 2022-07-08 | 2022-07-11 | $90.00 | $666K | -2.4% | +9.3% | -0.4% |
| BMRN | SELL | 2022-05-02 | 2022-05-04 | $80.38 | $2.5M | -8.1% | -7.9% | +3.0% |
| BMRN | SELL | 2022-03-21 | 2022-03-23 | $81.29 | $996K | -0.8% | -0.5% | -3.1% |
| BMRN | SELL | 2021-08-02 | 2021-08-04 | $76.69 | $846K | -1.8% | +11.0% | +8.6% |
| BMRN | SELL | 2021-05-03 | 2021-05-04 | $78.30 | $732K | -1.5% | -1.0% | -0.9% |
| BMRN | SELL | 2021-04-19 | 2021-04-20 | $79.58 | $431K | -2.4% | -0.9% | -1.3% |
| BMRN | SELL | 2020-05-01 | 2020-05-04 | $89.38 | $2.2M | +0.5% | +21.7% | +33.6% |
| BMRN | SELL | 2019-11-26 | 2019-11-27 | $79.66 | $508K | -0.8% | +6.9% | +13.7% |
| BMRN | SELL | 2019-03-25 | 2019-03-26 | $87.86 | $591K | +4.6% | -5.0% | -4.3% |
| BMRN | SELL | 2019-03-19 | 2019-03-21 | $93.92 | $1.5M | +1.1% | -7.2% | -5.8% |
| BMRN | SELL | 2018-09-14 | 2018-09-18 | $99.45 | $282K | -2.6% | +4.3% | -7.1% |
| BMRN | SELL | 2018-09-13 | 2018-09-17 | $99.57 | $1.2M | -0.1% | +8.2% | -5.7% |
| BMRN | SELL | 2018-03-23 | 2018-03-27 | $81.35 | $545K | +0.6% | +5.5% | +21.3% |
| BMRN | SELL | 2018-03-16 | 2018-03-20 | $83.88 | $641K | -7.9% | -0.3% | +13.9% |
| BMRN | SELL | 2018-03-05 | 2018-03-07 | $79.04 | $333K | +1.2% | -8.2% | +11.3% |
| BMRN | SELL | 2018-02-01 | 2018-02-05 | $90.66 | $2.7M | -1.5% | -4.0% | +0.6% |
| BMRN | SELL | 2017-11-30 | 2017-12-04 | $85.64 | $103K | +6.2% | +10.5% | -3.1% |
| BMRN | SELL | 2017-06-23 | 2017-06-27 | $96.60 | $1.9M | -0.6% | -3.4% | +4.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.